1 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 30 of 510 | 2020 prescriptions Less than 1% of all prescriptions | 1810 | 420 patients 15% of all patients | < 11 | |
2 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 40 of 500 | 1490 prescriptions Less than 1% of all prescriptions | 1320 | 340 patients 12% of all patients | < 11 | |
3 PREDNISONE | 20 of 470 | 2230 prescriptions Less than 1% of all prescriptions | 1870 | 940 patients 34% of all patients | < 11 | |
4 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 60 of 400 | 1400 prescriptions Less than 1% of all prescriptions | 1210 | 270 patients 10% of all patients | < 11 | |
5 SPIRIVA (TIOTROPIUM BROMIDE) | 90 of 470 | 800 prescriptions Less than 1% of all prescriptions | | 170 patients 6% of all patients | < 11 | |
6 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 40 of 420 | 1040 prescriptions Less than 1% of all prescriptions | 780 | 170 patients 6% of all patients | < 11 | |
7 PROAIR HFA (ALBUTEROL SULFATE) | 50 of 480 | 1060 prescriptions Less than 1% of all prescriptions | 920 | 450 patients 16% of all patients | < 11 | |
8 VENTOLIN HFA (ALBUTEROL SULFATE) | 90 of 490 | 1080 prescriptions Less than 1% of all prescriptions | 740 | 460 patients 17% of all patients | < 11 | |
9 FLUTICASONE PROPIONATE | 80 of 300 | 440 prescriptions Less than 1% of all prescriptions | | 190 patients 7% of all patients | < 11 | |
10 FLOVENT HFA (FLUTICASONE PROPIONATE) | 70 of 280 | 320 prescriptions Less than 1% of all prescriptions | 320 | 110 patients 4% of all patients | 110 patients 4% of all patients | |
11 MONTELUKAST SODIUM | 180 of 460 | 530 prescriptions Less than 1% of all prescriptions | 400 | < 11 | < 11 | |
12 PULMICORT FLEXHALER (BUDESONIDE) | 10 of 120 | 440 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 220 of 440 | 390 prescriptions Less than 1% of all prescriptions | 280 | 110 patients 4% of all patients | < 11 | |
14 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 20 of 90 | 380 prescriptions Less than 1% of all prescriptions | 260 | < 11 | < 11 | |
15 PANTOPRAZOLE SODIUM | 30 of 110 | 380 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 60 of 260 | 330 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | |
17 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 100 of 200 | 360 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 280 of 430 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 DULERA (MOMETASONE/FORMOTEROL) | 30 of 90 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 PROVENTIL HFA (ALBUTEROL SULFATE) | 10 of 20 | 260 prescriptions Less than 1% of all prescriptions | 260 | < 11 | < 11 | |
21 SEREVENT DISKUS (SALMETEROL XINAFOATE) | 50 of 110 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
22 ESBRIET (PIRFENIDONE) | 50 of 90 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
23 FLOVENT DISKUS (FLUTICASONE PROPIONATE) | 70 of 90 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
24 THEOPHYLLINE ANHYDROUS | 40 of 50 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
25 ENOXAPARIN SODIUM | 10 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
26 PRADAXA (DABIGATRAN ETEXILATE MESYLATE) | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
27 PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DI-HCL) | 30 of 40 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
28 CEFUROXIME (CEFUROXIME AXETIL) | 10 of 20 | 430 prescriptions Less than 1% of all prescriptions | | 290 patients 10% of all patients | < 11 | A |
29 NYSTATIN | 10 of 40 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 AZITHROMYCIN | 230 of 360 | 180 prescriptions Less than 1% of all prescriptions | | 150 patients 5% of all patients | < 11 | A |